Role of heat shock transcriptional factor 1 and heat shock proteins in cardiac hypertrophy

Cardiac hypertrophy is an independent risk factor for cardiovascular disease. Initially, cardiac hypertrophy is an adaptive response to increased wall stress, but sustained stress leads to heart failure. It remains unclear how the transition from adaptive cardiac hypertrophy to maladaptive cardiac hypertrophy occurs. It has been postulated that there are two forms of cardiac hypertrophy, which are physiologic and pathologic cardiac hypertrophy. Unlike pathologic cardiac hypertrophy caused by chronic pressure or volume overload, cardiac hypertrophy induced by exercise is associated with less fibrosis and better systolic function, suggesting that adaptive mechanisms may be involved in exercise-induced cardiac hypertrophy. Therefore, elucidation of the molecular differences between these two types of cardiac hypertrophy may provide insights into the mechanisms underlying the transition from adaptive cardiac hypertrophy to heart failure. By comparing the two types of cardiac hypertrophy, we have identified heat shock transcription factor I and its target heat shock proteins as key factors involved in the adaptive mechanism of cardiac hypertrophy. In this review, we summarize the protective role of heat shock transcription factor I and heat shock proteins in cardiovascular disease.